eToro is planning to raise around $620 million in an upsized U.S. initial public offering (IPO) priced above market range, the company said on Tuesday. The stock and cryptocurrency trading platform ...

Exelixis delivers a strong Q1 performance with raised 2025 guidance, robust Cabometyx sales, and share buybacks. Read the ...

Shares of stock brokerage platform eToro popped in their Nasdaq debut on Wednesday after the company raised almost $310 million in its IPO. The stock opened at $69.69, or 34% above its IPO, pushing ...

The offering is being led by Morgan Stanley, Goldman Sachs Group Inc. and JPMorgan Chase & Co. The company plans for its ...

Toro raises $620 million in IPO, pricing shares at $52 each above expected range, with trading to begin May 14 on Nasdaq.

The stock brokerage and burgeoning crypto platform eToro is stepping into the Wall Street spotlight, having priced its ...

If the stock market rally continues, other quality companies that had put their IPO plans on hold are likely to follow,” one ...

Israel-based stock brokerage platform eToro said it has priced shares for its IPO at $52, which would value the company at ...

April may not have brought rain to med-tech, but tariffs and financial uncertainty certainly dampened the enthusiasm for IPOs. With those clouds lifting, three companies – Hinge Health Inc., ...

Chime is a technology company, not a bank,” the company said in its prospectus, noting it’s not a member of the U.S. Federal ...

Britain's GSK and drug developer iTeos Therapeutics said on Tuesday they have stopped developing an experimental lung cancer ...

Hinge Health said on Tuesday that it expects a valuation of up to $2.6B in its initial public offering in the U.S., filed in ...